1. Home
  2. AVBP vs KRNT Comparison

AVBP vs KRNT Comparison

Compare AVBP & KRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • KRNT
  • Stock Information
  • Founded
  • AVBP 2021
  • KRNT 2002
  • Country
  • AVBP United States
  • KRNT Israel
  • Employees
  • AVBP N/A
  • KRNT N/A
  • Industry
  • AVBP
  • KRNT Industrial Machinery/Components
  • Sector
  • AVBP
  • KRNT Industrials
  • Exchange
  • AVBP NYSE
  • KRNT Nasdaq
  • Market Cap
  • AVBP 862.8M
  • KRNT 933.7M
  • IPO Year
  • AVBP 2024
  • KRNT 2015
  • Fundamental
  • Price
  • AVBP $18.66
  • KRNT $18.65
  • Analyst Decision
  • AVBP Strong Buy
  • KRNT Strong Buy
  • Analyst Count
  • AVBP 8
  • KRNT 5
  • Target Price
  • AVBP $38.38
  • KRNT $33.20
  • AVG Volume (30 Days)
  • AVBP 239.9K
  • KRNT 205.0K
  • Earning Date
  • AVBP 08-13-2025
  • KRNT 08-06-2025
  • Dividend Yield
  • AVBP N/A
  • KRNT N/A
  • EPS Growth
  • AVBP N/A
  • KRNT N/A
  • EPS
  • AVBP N/A
  • KRNT N/A
  • Revenue
  • AVBP N/A
  • KRNT $206,506,000.00
  • Revenue This Year
  • AVBP N/A
  • KRNT $10.86
  • Revenue Next Year
  • AVBP N/A
  • KRNT $12.68
  • P/E Ratio
  • AVBP N/A
  • KRNT N/A
  • Revenue Growth
  • AVBP N/A
  • KRNT N/A
  • 52 Week Low
  • AVBP $15.47
  • KRNT $13.59
  • 52 Week High
  • AVBP $36.37
  • KRNT $34.29
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 29.95
  • KRNT 34.33
  • Support Level
  • AVBP $21.10
  • KRNT $20.82
  • Resistance Level
  • AVBP $22.29
  • KRNT $22.06
  • Average True Range (ATR)
  • AVBP 1.02
  • KRNT 0.89
  • MACD
  • AVBP -0.29
  • KRNT -0.20
  • Stochastic Oscillator
  • AVBP 2.38
  • KRNT 1.45

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About KRNT Kornit Digital Ltd.

Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.

Share on Social Networks: